Douglass Winthrop Advisors, LLC Organon & Co. Transaction History

Douglass Winthrop Advisors, LLC

  • $5.09 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$28.67 - $37.13 $292,606 - $378,948
-10,206 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$28.63 - $35.64 $2.9 Million - $3.61 Million
-101,200 Reduced 90.84%
10,206 $335,000
Q2 2021

Aug 02, 2021
BUY
$28.45 - $38.0 $3.17 Million - $4.23 Million
111,406 New
111,406 $3.37 Million

Others Institutions Holding OGN

# of Institutions
789
Shares Held
201M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.06B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email